Olaparib brand name Lynparza

  • 1 reply
  • 44 subscribers
  • 117 views

This drug has just been passed by NICE for use for men with advanced prostate cancer and Women with aggressive breast cancer, with mutations BRCA1 and BRCA2 this should help around 550 men and 300 women per year, a 2 week course costs less than £2500.

  • That's really good, i know when i was diagnosed,, 6 months later nice passed a immunotherapy drug, and i was my oncologist first patent to go ,  it, and do two years.

    Always some thing new coming along, yesterday on the news, they where saying another,  one is on  the horizon for lung cancer, Onwards  and Upwards,.